Fidia Pharma USA Inc.
Fidia is committed to compliantly assisting our customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. The ASP file, the basis for setting reimbursement, becomes effective July 1, 2022. Read the full communication sent to customers of Fidia Pharma USA Inc. and learn how to contact us for more information and assistance.
The industry’s only 2-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain
A 3-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain
The original safe, proven hyaluronic acid treatment for osteoarthritis (OA) knee pain
An acellular, shelf-stable, amniotic membrane-derived injectable allograft, which retains rich intrinsic beneficial properties of the amniotic membrane
NEW from Fidia Pharma USA Inc. Quality, consistency, and reliability—all in one cost-effective PRP system
Hyaluronic acid-based gel and suppositories that provide temporary relief of vaginal dryness symptoms
Click OK to continue or Cancel to stay on current page.